PBGENE-DMD is Precision's wholly-owned, first-in-class in vivo gene editing program utilizing a gene excision approach intended to permanently correct the dystrophin gene in patients with mutations ...

Hatch and Maaden signing ceremony From left to right, Andrea De Mori, global managing director, Metals, Hatch; Joe Lombard, ...

Nisun International Enterprise Development Group Co., Ltd (the “Company”) (NASDAQ: NISN), today announced that at the opening of trading on February 12, 2026, the Class A common shares of the Company ...

His Highness Sheikh Mohammed Bin Rashid Al Maktoum, Vice President, Prime Minister and Ruler of Dubai, approved the Al Layan ...

PRNewswire/ - MolecuLight today announced that its MolecuLightDX(R) wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). The ...

Application for 10 year residency programme for entrepreneurs and senior executives opens at Qatar Manpower Solutions Company ...

According to provisional data compiled by the Federal Board of Revenue (FBR), salaried individuals paid Rs315 billion in ...

Hatch, a global leader in engineering, project delivery, and professional services, has been selected by Maaden (Saudi Arabian Mining Company) as ...

The total number of buildings served by Empower with district cooling services grew to 1,747 in 2025, a 7% increase from 2024 ...

Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027. Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be rep ...

Daniel Kirby, Chief Commercial Officer of Iovance, stated, "The real world Amtagvi data with impressive response rates, paired with unprecedented five-year durability and survival data, demonstrate a ...